DR. DMITRIY BERENZON MD NPI 1669631479

NPI Information

  • NPI: 1669631479
  • Provider Name: DR. DMITRIY BERENZON, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 159 BARNEGAT RD STE 101
    POUGHKEEPSIE, NY
    ZIP 12601
  • Phone: (845) 454-1942

Map and Directions

Get Directions

NPI Details

DR. Dmitriy Berenzon, MD is a hematology and oncology internal medicine in Poughkeepsie, NY with 31 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Dmitriy Berenzon, MD NPI is 1669631479. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

159 BARNEGAT RD STE 101
POUGHKEEPSIE, NY
ZIP 12601-402
Phone: (845) 454-1942
Fax: (845) 452-4638

The NPI 1669631479 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg (HCPCS:J2916)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Transferrin (iron binding protein) level (HCPCS:84466)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Folic acid level, serum (HCPCS:82746)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Nephelometry, test method using light (HCPCS:83883)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Magnesium level (HCPCS:83735)
  • Beta-2 microglobulin (protein) level (HCPCS:82232)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • Phosphate level (HCPCS:84100)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Blood test, clotting time (HCPCS:85610)
  • Thyroid hormone, t3 measurement, total (HCPCS:84480)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Uric acid level, blood (HCPCS:84550)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Vitamin d-3 level (HCPCS:82306)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Thyroglobulin (thyroid protein) antibody measurement (HCPCS:86800)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
  • Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
  • Rheumatoid factor level (HCPCS:86431)
  • Bilirubin level, direct (HCPCS:82248)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Aspiration of bone marrow sample for diagnosis (HCPCS:38220)
  • Biopsy of bone marrow (HCPCS:38221)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Analysis for antibody borrelia burgdorferi (lyme disease bacteria) (HCPCS:86618)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)

The enumeration date for this NPI number is 6/6/2008 and was last updated on 3/26/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology245284NEW YORKYes
2207RH0003XInternal MedicineHematology & Oncology2010-00928NORTH CAROLINANo

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.